Suppr超能文献

能够调节前体mRNA聚腺苷酸化的新型聚腺苷酸聚合酶抑制蛋白的鉴定。

Identification of new poly(A) polymerase-inhibitory proteins capable of regulating pre-mRNA polyadenylation.

作者信息

Ko Bom, Gunderson Samuel I

机构信息

Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08854, USA.

出版信息

J Mol Biol. 2002 May 17;318(5):1189-206. doi: 10.1016/s0022-2836(02)00240-1.

Abstract

The 3' ends of nearly all eukaryotic pre-mRNAs undergo cleavage and polyadenylation, thereby acquiring a poly(A) tail added by the enzyme poly(A) polymerase (PAP). Two well-characterized examples of regulated poly(A) tail addition in the nucleus consist of spliceosomal proteins, either the U1A or U170K proteins, binding to the pre-mRNA and inhibiting PAP via their PAP regulatory domains (PRDs). These two proteins are the only known examples of this type of gene regulation. On the basis of sequence comparisons, it was predicted that many other proteins, including some members of the SR family of splicing proteins, contain functional PRDs. Here we demonstrate that the putative PRDs found in the SR domains of the SR proteins SRP75 and U2AF65, via fusion to a heterologous MS2 RNA binding protein, specifically and efficiently inhibit PAP in vitro and pre-mRNA polyadenylation in vitro and in vivo. A similar region from the SR domain of SRP40 does not exhibit these activities, indicating that this is not a general property of SR domains. We find that the polyadenylation- and PAP-inhibitory activity of a given polypeptide can be accurately predicted based on sequence similarity to known PRDs and can be measured even if the polypeptides' RNA target is unknown. Our results also indicate that PRDs function as part of a network of interactions within the pre-mRNA processing complex and suggest that this type of regulation will be more widespread than previously thought.

摘要

几乎所有真核生物前体mRNA的3'末端都会经历切割和聚腺苷酸化,从而获得由聚腺苷酸聚合酶(PAP)添加的聚(A)尾巴。在细胞核中,两个已得到充分表征的受调控聚(A)尾巴添加的例子涉及剪接体蛋白,即U1A或U170K蛋白,它们与前体mRNA结合并通过其PAP调节结构域(PRD)抑制PAP。这两种蛋白是此类基因调控仅有的已知例子。基于序列比较,据预测许多其他蛋白,包括剪接蛋白SR家族的一些成员,都含有功能性PRD。在此我们证明,通过与异源MS2 RNA结合蛋白融合,在SR蛋白SRP75和U2AF65的SR结构域中发现的推定PRD,在体外能特异性且高效地抑制PAP,并在体外和体内抑制前体mRNA的聚腺苷酸化。来自SRP40的SR结构域的类似区域不具有这些活性,表明这并非SR结构域的普遍特性。我们发现,基于与已知PRD的序列相似性,可以准确预测给定多肽的聚腺苷酸化和PAP抑制活性,即使该多肽的RNA靶点未知也能进行测量。我们的结果还表明,PRD作为前体mRNA加工复合体中相互作用网络的一部分发挥作用,并提示这种调控类型比之前认为的更为普遍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验